|
Thymus Neoplasms
|
C04.588.894.949 |
|
|
Pyelocystitis
|
C12.777.829.495.750 |
|
|
Povidone
|
J01.637.051.720.716.721.838 |
|
|
Marchiafava-Bignami Disease
|
C10.228.140.163.510 |
|
|
Apolipoprotein L1
|
D12.776.070.400.750.500 |
|
|
Apolipoproteins L
|
D12.776.070.400.750 |
|
|
Betacellulin
|
D12.776.467.382.374 |
|
|
EGF Family of Proteins
|
D12.776.467.382 |
|
|
Laboratory Infection
|
C01.503 |
|
|
Receptors, Kainic Acid
|
D12.776.543.585.400.500.200.200 |
|
|
Cell Physiological Phenomena
|
D002468 |
[Cellular processes, properties, and characteristics.
] |
|
Cell Separation
|
D002469 |
[Techniques for separating distinct populations of cells.
] |
|
T Follicular Helper Cells
|
A15.145.229.637.555.567.550.500.400.250 |
|
|
T-Lymphocytes, Helper-Inducer
|
A15.145.229.637.555.567.550.500.400 |
|
|
Mitochondrial Encephalomyopathies
|
C10.228.140.163.540 |
|
|
Cell Membrane
|
D002462 |
[The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells.
] |
|
Glycosuria
|
C12.777.934.363 |
|
|
Cell Membrane Permeability
|
D002463 |
[A quality of cell membranes which permits the passage of solvents and solutes into and out of cells.
] |
|
Cell Line
|
D002460 |
[Established cell cultures that have the potential to propagate indefinitely.
] |
|
Melanotrophs
|
A06.300.747.750.500 |
|
